Competition record
Cencora
Deep profile · 0 linked library matters
Cencora, formerly AmerisourceBergen, is the third US drug wholesaler beside McKesson and Cardinal Health. Its distinctive piece is specialty distribution into oncology practices, plus Alliance Healthcare in Europe and MWI in animal health.
Overview
Cencora is based in Conshohocken, Pennsylvania. It delivers branded, generic, and specialty drugs to health systems, retail pharmacies, and physician offices, and it still carries the AmerisourceBergen name in many customer contracts.
Oncology practices often receive refrigerated cancer drugs through Cencora's specialty units rather than through a retail wholesaler. That service includes verification and just-in-time delivery, which a manufacturer's limited network can reassign to one specialty distributor.
Alliance Healthcare gives Cencora a European wholesale footprint, and MWI distributes animal-health products to veterinary clinics, a channel Zoetis and Elanco also use. Those adjacencies are not what Cardinal or McKesson lead with, and they are why a Cencora customer list is broader than US retail pharmacy.
Competition footprint
US full-line wholesale remains a three-company structure with McKesson and Cardinal Health.
Community oncology practices depend on a specialty wholesaler that can handle cold-chain cancer drugs.
MWI is a route into veterinary clinics that overlaps Zoetis's commercial efforts.
Consumer & business angle
An oncology practice that loses its specialty distributor cannot infuse patients that week.
European pharmacies served by Alliance Healthcare see Cencora as local logistics, not as a US brand.
What to watch
- Manufacturer decisions to narrow specialty oncology distribution to one or two wholesalers.
- European wholesale tenders for Alliance Healthcare and vet-clinic contracts at MWI.
Markets
drug wholesale · specialty oncology distribution · animal health distribution
Also known as: amerisourcebergen, alliance healthcare
Conduct themes
Linked cases in the library
No linked matters in the current library yet. The narrative above is still a market-power primer — check primary sources for live disputes.